| 764558 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
803 Immune-related adverse events correlate with improved outcomes in patients with advanced non-small cell lung cancer treated with combinations of immune-checkpoint inhibitors and chemotherapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.803 |
Shantzer Lindsey, Dougherty Sean, Novicoff Wendy, Melson John, Reed Daniel, Lynch Alia, Gentzler Ryan, Hall Richard |
| 764557 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
802 An electronic health record-based approach to identify and characterize patients with immune checkpoint inhibitor-associated arthritis |
2021-11-01 |
10.1136/jitc-2021-sitc2021.802 |
Tran Steven, Rasmussen Luke, Pacheco Jennifer, Galvez Carlos, Tegtmeyer Kyle, Luo Yuan, Sosman Jeffrey, Kho Abel, Walunas Theresa |
| 764556 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
650 Target the activin receptor 1c on CD4+ T cells to achieve anti-tumor therapeutic effects |
2021-11-01 |
10.1136/jitc-2021-sitc2021.650 |
Zheng Ying, Lebid Andriana, Pardoll Andrew, Fu Juan, Patel Chirag, Wang Xiaoxu |
| 764555 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
649 Efferocytosis drives myeloid inflammasome signaling and Gasdermin D independent secretion of IL-1β to promote tumor growth |
2021-11-01 |
10.1136/jitc-2021-sitc2021.649 |
Roy Sohini, Lang Cara, Wang Yu, Graves Diana, Yaomin Xu, Kim Young |
| 764554 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
648 T cell intrinsic caspase 1 signaling negatively regulates T cell anti-tumor response |
2021-11-01 |
10.1136/jitc-2021-sitc2021.648 |
Kim Young, Korrer Michael, Lang Cara |
| 764553 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
647 Possibility of immunotherapy for the glioblastoma patients with O6-methyl-guanine DNA methyltransferase (MGMT) expression or promoter unmethylated |
2021-11-01 |
10.1136/jitc-2021-sitc2021.647 |
Kushihara Yoshihiro, Kobayashi Yukari, Nagaoka Koji, Kakimi Kazuhiro |
| 764552 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
645 Single-cell transcriptional and clonal characterization of CD4+ T cells across tissues in long-term melanoma survivors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.645 |
Han Jichang, Zhao Yanding, Shirai Keisuke, Searles Tyler, Khatwani Nikhil, Vella Jennifer, Haidar Fatima, Kolling Fred, Gui Jiang, Cheng Chao, Turk Mary, Angeles Christina |
| 764551 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
644 Tumor-mediated suppressive signaling and hypoxia supports altered chromatin landscapes that limit the transcriptional and functional potential of terminal T cell exhaustion |
2021-11-01 |
10.1136/jitc-2021-sitc2021.644 |
Ford Rhodes, Rittenhouse Natalie, Scharping Nicole, Vignali Paolo, Delgoffe Greg, Poholek Amanda |
| 764550 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
643 Vasoactive intestinal peptide as a novel immune checkpoint molecule in activated T cells |
2021-11-01 |
10.1136/jitc-2021-sitc2021.643 |
Ravindranathan Sruthi, Fnu Tenzin Passang, Waller Edmund |
| 764549 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
642 Decreased host PKC-delta is associated with the T cell-inflamed tumor microenvironment and improves anti-tumor immunity |
2021-11-01 |
10.1136/jitc-2021-sitc2021.642 |
Cron Kyle, Sivan Ayelet, Aquino-Michaels Keston, Higgs Emily, Fessler Jessica, Lee Seoho, Sweis Randy, Gajewski Thomas |
